Objective: Necrotizing enterocolitis (NEC) remains a major cause of neonatal morbidity and mortality. Some infants recover uneventfully with medical therapy whereas others develop severe disease (that is, NEC requiring surgery or resulting in death). Repeated attempts to identify clinical parameters that would reliably identify infants with NEC most likely to progress to severe disease have been unsuccessful. We hypothesized that comprehensive prospective data collection at multiple centers would allow us to develop a model which would identify those babies at risk for progressive NEC.
Introduction
Necrotizing enterocolitis (NEC) is the most common serious gastrointestinal disease among neonates and a leading cause of morbidity and death in neonatal intensive care units (NICUs). The only consistently demonstrable risk factor for NEC is prematurity. Approximately one-half of infants with NEC will recover fully with bowel rest and antibiotics whereas the other half will develop severe disease requiring urgent surgical intervention. 1, 2 Up to one-half of the patients with serious disease will die and a significant proportion of the survivors will suffer long-term growth, gastrointestinal and neurodevelopmental consequences. [3] [4] [5] The ability to understand why certain infants are at risk for severe disease would enhance our understanding of NEC and open doors for prevention and treatment. Multiple previous investigations have attempted to develop prediction models based upon clinical parameters. Most of these efforts involved retrospective case series reviews at single institutions and were, therefore, limited by their retrospective nature and inability to achieve desired power. We aimed to bring the strength of a multi-institutional prospective analysis to develop a clinical model that would predict the risk of an infant with NEC progressing to severe disease. We hypothesized that rigorous prospective data collection of a sufficient number of patients would allow us to create a model to predict outcome in infants with NEC using clinical parameters at the time of diagnosis.
Methods
This observational, prospective cohort study was conducted at six university medical centers in the United States: Texas Children's Hospital, Houston; Children's Hospital, Boston; Lucille S Packard Children's Hospital, Stanford; Mattel Children's Hospital, Los Angeles; University of California Children's Hospital, San Francisco, and Yale-New Haven Children's Hospital. The protocol was approved by the Investigational Review Board at each site and informed consent was obtained when required; consent waivers were granted at some sites. The entry criteria for this study (Table 1) are those commonly used to identify infants with suspected or diagnosed NEC. 6 Subjects entered the study at the time they met the criteria.
Study endpoints were defined as achieving full enteral feedings (100 kcal kg À1 per day and a mean weight gain of X15 g per day for 7 days), undergoing gastrointestinal surgery, or dying. For purposes of analysis, study subjects reaching full feedings without surgical intervention were defined as 'nonprogressors', whereas those requiring an operation for NEC or who died from NEC without undergoing surgery were defined as 'progressors' to severe disease. Subjects were excluded if they were lost to follow-up before reaching full feedings, surgery, or death or if reclassified as having a diagnosis other than NEC.
Demographic, maternal, antenatal and intrapartum data, medication histories for both mother and child, and newborn history through the date of study entry were abstracted from medical records. Daily feeding data were collected during the week before diagnosis including mode of feeding (parenteral or enteral), method (bolus or continuous), type (breast milk, formula, total parenteral nutrition or a combination), volume and the weight of the infant.
Detailed clinical data were then collected prospectively on a daily basis until the first study endpoint, at which time study follow-up ended for subjects who had reached full feedings, received another diagnosis or died. For those whose first endpoint was surgery, data were then collected on a weekly basis until full feedings, death or discharge from the hospital. Those discharged from the hospital before achieving full feedings were followed every 6 months until they achieved full feedings or for 2 years from diagnosis.
The prospective methodology allowed for accurate and timely retrieval of missing data as clinical providers were available to the research nurses on a daily basis. The data collected included medications, laboratory and imaging evaluations, ventilation status, fluid/hemodynamic status, positive blood cultures, and detailed feeding regimens. If an operation was performed, surgical findings and postoperative course data were recorded while the patient remained hospitalized.
Statistical methods
The objective of the analysis was to identify independent risk factors for progression to severe disease from clinical information available at the time of initial diagnosis. During the first stage of the analysis, factors were selected from among demographic, clinical and laboratory variables collected at enrollment. A total of 22 variables were deemed clinically or statistically promising based on univariate analysis using Fisher's exact test, the Cochran-Armitage trend test (for ordered categorical variables) or the Wilcoxon's rank sum test.
The rest of the modeling process utilized the LOGISTIC procedure in SAS 9.1 to perform multivariable logistic regression. Associations were expressed as odds ratios (ORs) 7, 8 and R 2 was defined following Nagelkerke. 9 Several continuous factors were Patients must meet at least one criterion from each of the following three categories to be enrolled into the study Historical factors categorized using clinically meaningful cut-points. Ultimately, all variables in our regression models were binary. Confidence intervals were based on profile likelihoods and P-values were based on Wald's tests. All P-values are two sided. Factors with missing data for substantial proportions of the sample were transformed into pairs of binary variables: one indicating absence of data and the other indicating the outcome of interest. The pair of variables was always considered together in a model, but the pair was retained or dropped based only on the parameter of interest, and only this parameter was reported. This transformation allowed patients with missing data on some predictors to remain in the multivariable models, thus contributing information when present.
The rate of increase or decrease of enteral feeding (volume per kg per day) was calculated by least squares within subjects having at least 2 days of enteral feeding data over each period of interest (2 to 4, 2 to 7 and 5 to 7 days before diagnosis). We ignored the day of and day before diagnosis because enteral feeds were reduced or stopped in many subjects as the diagnosis became clinically apparent. This isolated the feeding pattern before the influence of the diagnosis.
Logistic modeling began by considering separate small groups of clinically related variables. Five variables were discarded at this stage because they were either clinically or statistically related to other variables in the group. We then used step-down selection on the remaining 17 variables, and finally checked whether any previously discarded variables should enter back into the model. To enhance interpretability we chose to retain two variables, Gram positive sepsis and birth weight <1000 g, in the final model even though their P-values were slightly larger than 0.05.
Results
We enrolled 473 infants from February 2004 through February 2007 ( Figure 1 ). A total of 18 subjects were excluded from analysis: 9 were lost to follow-up after a median of 9 days (range 0 to 29) and 9 were found to have diseases other than NEC after a median of 25 days (range 2 to 56). Demographic information for the Risk factors for the progression of NEC RL Moss et al remaining 455 subjects is displayed in Table 2 . Of 455 patients analyzed, 263 (58%) achieved full feedings without undergoing operation for NEC, and 192 (42%) met our criteria for progression (180 (40%) underwent operation and 12 (3%) died without undergoing surgery at a median of 16 days after diagnosis; Figure 1 ). The median and mean times from NEC diagnosis to severe disease resulting in an operation were 1 and 6 days, respectively. Of the 180 surgical patients, 75 (42%) received an operation on the day of diagnosis, 37 (21%) on the following day and an additional 30 (17%) later in the first week. The remaining 38 (20%) subjects required operation less acutely, between day 8 and day 60 after diagnosis. Of those who underwent operation, 31% died, 64% achieved full feedings and 5% were alive and had not reached full feedings at the time of data analysis.
Univariate analysis
An initial univariate analysis of our extensive database revealed variables that were statistically associated with progression. These parameters and a few additional variables, which almost reached statistical significance, were included for further analysis because of their clinical relevance. Initial variables were found in each of the five major categories examined: demographics (Table 2) , maternal factors (antepartum and intrapartum), neonatal at birth, neonatal subsequent to birth (Tables 3) and feeding-related variables (Table 4) .
Multivariate analysis
In the multivariate analysis, 12 risk factors were found to be independent predictors of disease progression to severe NEC (Table 5 ). These factors explained about half of the total variation of the outcome variable (R 2 ¼ 46%). Three factors not previously described as risks for severe disease were having a teenaged mother, having never received enteral feeding before diagnosis, and receiving cardiac compressions and/or resuscitative drugs at the time of delivery (Table 5 ). Nine previously described risks for severe disease were confirmed; they included Gram negative [10] [11] [12] [13] and Gram positive 11, 14 bacteremia, abdominal wall discoloration, 6 radiographic findings of portal venous gas and of pneumatosis intestinalis, 6,10,15 metabolic acidosis on day of diagnosis (defined as pH <7.3 or HCO 3 <16 mequiv. l À1 ), 13, 15 bandemia >5%, male gender 16 and birth weight <1000 g.
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Feeding risk factors
The only feeding-related parameter associated with progression to severe disease was the absence of enteral feeding before diagnosis of NEC (OR 2.41, CI 1.08 to 5.52; Table 5 ). Thirty-one of 47 (66%) infants who had never received enteral feedings before diagnosis progressed to severe disease compared with 149 of 393 (38%) previously fed infants. Progression to severe disease was more common in such infants even controlling for age at diagnosis (Mantel-Haenszel test P ¼ 0.001; Figure 2 ). Mortality in infants who never received enteral feedings before diagnosis was 19% (9/ 47) vs 14% (56/393) in infants who did (P ¼ 0.38). No other aspects of enteral feeding correlated with progression of disease including the method of feeding (continuous or bolus), type of feeding (formula or breast milk) and rate of advancement of feeding (Table 4) . Parenteral feeding before diagnosis also did not correlate with disease progression.
Severe perinatal stress Extreme resuscitative efforts including cardiac compressions and the use of resuscitative drugs at birth was associated with progression to severe NEC (OR, 2.51, CI, 1.17 to 5.48; Table 5 ). Thirty of 48 (63%) infants who received such interventions progressed to severe disease compared with 160 of 402 (40%) who did not. However, no other measures of perinatal stress could be correlated with progressive disease. Neither low Apgar scores, oxygen use, bag mask ventilation, nor intubation at delivery were predictive of progression. Mortality in subjects who received cardiac compressions and resuscitative drugs at birth was 25% (12/48) vs 14% (58/402) in infants who did not receive such interventions (P ¼ 0.09).
Maternal factors
The only maternal factor correlated with progression was maternal age <20 years. No other maternal risk factors studied correlated with progression to severe disease in the infant, either in the initial univariate analysis or after multivariate adjustment for other factors. These included, but were not limited to, previous delivery of an infant with congenital abnormalities, absence of prenatal care, abnormal fetal or placental ultrasound, amniocentesis (even if results were abnormal), preexisting or gestational diabetes and/or hypertension, number of fetuses, eclampsia, induction of labor, mode of delivery, the maternal use of steroids, indomethacin, terbutaline, nifedipine, progesterone, magnesium sulfate, insulin, antibiotics, and/or illicit drug use during pregnancy. 
Neonatal factors
Potential neonatal risk factors that proved not to be predictive of risk for progression of disease in the final model included race/ ethnicity, use of continuous positive airway pressure and ventilator dependence. The occurrence of episodic apnea and bradycardia, arterial oxygen desaturation, feeding regimens (other than absence of enteral feeding), feeding intolerance, prolonged capillary refill time, abdominal distention and bloody stools proved nonsignificant, as did the diagnosis, medical and surgical treatment of patent ductus arteriosus (PDA) as well as the use of corticosteroids, vasopressors (nearly always dopamine), nonsteroidal anti-inflammatory drugs and surfactant. Elevated and reduced white blood cell count (WBC), hematocrit >30%, thrombocytopenia (defined as platelet counts <100 000, 75 000, 50 000 or 25 000 ml À1 ), bandemia, and fungemia did not correlate with disease progression. Radiographic findings of ileus, thickened bowel walls, air fluid levels and even the broad category of abnormal gas pattern were not linked to progression.
Discussion NEC continues to be a major clinical problem for infants born prematurely. It occurs in 1.1/1000 live births in the United States and accounts for 3 to 7.5% of all admissions to NICUs affecting 12 to 15% of all infants with birth weights <1500 g. [17] [18] [19] Rationale for studying progression to severe disease Despite more than 30 years of concentrated research efforts there are currently no effective interventions to prevent the development of NEC and its progression. Because we believed it important to understand why some infants with NEC recover uneventfully with medical therapy whereas others develop severe progressive disease, our collaborative committed to a prospective methodology with extensive clinical data collection in order to study disease progression in infants with NEC. In addition to enhancing our understanding of pathophysiology and identifying, conclusively, clinical factors for progressive disease, we hoped that our model could be used to select the best candidates for novel treatment protocols and for clinical trials of new agents designed to mitigate the effects of NEC in the future.
Overall assessment of the model Although we established an extensive database and identified several clinical parameters associated with progressive NEC, our study results, although valid, were not adequate to predict which infants are at high risk of progression based solely upon clinical factors at the time of diagnosis. Even though our findings provided some insights, our model, at best, accounted for only a moderate degree of variation in our primary outcome variable (R 2 ¼ 46%). Of the 12 independent predictors of progressive NEC, 9 were factors previously identified or intuitively obvious and only 1 of the 12 (that is, whether a newborn is ever fed (before diagnosis)) can potentially be altered by the clinician.
Our most notable finding was that most variables, when studied prospectively, proved nonpredictive of NEC progression. Most variables listed in the five major categories in Tables 2, 3, and 4 have, at one time or another, been shown to be implicated in NEC and its progression. Even though most previous studies were small and retrospective in design, we expected the findings of our prospective study to have more concurrence with previous studies than that which we found. We were impressed that many long-held beliefs regarding the risk factors for NEC and its progression were discounted and that our significant finding were so few. Even though this study did not identify new risk factors or lead to suggested changes in clinical management, we believe it is worthy of report. On the basis of our analysis of this large prospective database, we conclude that clinical parameters alone are not sufficiently predictive of an infant's risk for progressive NEC.
Feeding issues
The most notable feeding-related finding in this study was the high risk for progression of NEC to severe disease posed by having never received enteral feeding before diagnosis. The role of feeding practices has long been implicated in the development of NEC in premature infants. In 1982, Marchildon et al. 20 described the occurrence of NEC in a group of 14 infants who had never been enterally fed. Fifty percent of this group progressed to severe disease. Our finding that an absence of enteral feeding is an independent risk factor for severe disease has not been previously described. Because we realize that infants diagnosed early in life have less opportunity to start enteral feeding before diagnosis than those diagnosed later, we considered whether the relationship between progression of NEC and never having received enteral feeding was a surrogate for a relationship between progression and age at diagnosis. However, the association with enteral feeding was present even when controlling for age at diagnosis (P ¼ 0.001, Mantel-Haenszel test).
The impact of feeding on the incidence and progression of NEC is controversial. Prior investigations of the incidence of NEC have yielded varying results. Four prior randomized trials found that more rapidly advancing feeding regimens in premature infants resulted in more rapid attainment of birth weight and shorter time to full feedings without increasing the incidence of NEC. [21] [22] [23] [24] A case-control study found that infants who developed sepsis had feedings initiated later than infants who did not, but that infants who developed NEC were fed at the same age (3 to 4 days) as infants who did not. 25 In contrast, a randomized trial, comparing rapid vs slow advancement of feeding was discontinued early because of an increase in NEC in the rapid advancing group. 26 The infants in both groups had never been enterally fed before enrollment at day 9 or 10 of life. These findings have not been confirmed by others.
Several investigators have contended that early initiation of feeding (gut priming) is critical to the development of normal intestinal barrier function and colonization with appropriate commensal organisms.
12,27-30 A randomized trial of early 'gutpriming' vs later initiation of feedings reported numerous physiologic advantages of priming without a corresponding increase in the incidence NEC. 30 A systematic review of early 'trophic' feeding found two small trials that showed no increase in NEC with trophic feeding but concluded that the issue had been insufficiently investigated to draw firm conclusions. 31 Almost all prior feeding studies were comprised of small numbers of patients. The resulting confidence intervals around the incidence of NEC were wide and could not rule out the possibility that more aggressive feeding protocols might be related to an increased incidence of NEC. [31] [32] [33] To our knowledge, the impact of gut priming on the progression of NEC to severe disease has not been previously investigated. However, many investigators believe there is a physiologic basis to support a potential protective effect. Rothman et al. 34 showed that starvation in newborn rabbits reduced mucosal barrier function. In neonatal piglets, increasing quantities of early enteral feeding was associated with growth and health of the intestinal mucosa. 35 Although early feeding may decrease the likelihood of progression to severe NEC, it is possible that early feeding may increase the incidence of NEC, even though a smaller proportion of those feeders will progress to severe disease. Our results showed that infants who were fed before diagnosis were less likely to progress to severe disease and suggests that when NEC develops, unfed infants may be less well equipped to avoid disease progression, although, at this time, we would not recommend a change in feeding strategies based on these findings.
Teenaged mother
Teenaged mothers were more than three times as likely to have infants who progressed to severe disease than older mothers. The reason is not clear, but may be linked to socioeconomic status and its accompanying stresses; factors that we did not study.
Severe perinatal stress at birth To our knowledge, this is the first report that extreme physiologic stress at birth, in the form of cardiorespiratory arrest is a risk factor for progression of NEC, if NEC occurs. It seems intuitive that severely stressed neonates could be less able to deal with future stresses such as NEC.
Conclusion
An extensive clinical database was established during this study. Notably, only three new independent predictors for progression to severe NEC were identified. Of most interest was the large number of clinical parameters previously implicated in NEC and its progression that proved not to be associated with progressive disease. As this study was observational, we were unable to assign cause and effect.
We conclude that analysis of clinical parameters alone have not and will not provide sufficient insight into the behavior of NEC and that future studies must include consideration of more advanced biologic parameters and that testing using high-throughput proteomic and genomic techniques may be more elucidating. The large epidemiologic database our consortium has established will provide the foundation upon which future examination of bioinformatics, proteomics and genomics, will be grounded.
